Innovative Infection Control Prescient Surgical specializes in advanced tools to combat surgical site infections, with flagship product CleanCision™ actively cleansing and protecting incisions. This innovative technology offers a compelling value proposition for hospitals seeking to reduce infection rates and improve patient outcomes.

Hospital Collaborations The company's ongoing collaboration with healthcare providers and its recent successful group purchasing agreement with Premier suggest a strong foothold in the hospital market, indicating potential for expanded procurement opportunities across surgical departments.

Growth & Recognition Having received a $10 million Series B funding round led by Baxter Ventures and recognition as a finalist at the Medical Design Excellence Awards, Prescient Surgical demonstrates growth potential and industry validation, making it an attractive partner for strategic alliances and sales expansion.

Tech-Forward Approach Leveraging modern digital tools and innovative active cleansing technology, Prescient Surgical positions itself as a relevant solution provider for hospitals aiming to enhance surgical safety through cutting-edge technology, which aligns with the ongoing trend toward technologically advanced surgical solutions.

Small & Focused Market With a small team and revenue under one million dollars, Prescient Surgical presents an opportunity for targeted outreach to decision-makers focused on infection prevention and patient safety, facilitating personalized sales strategies and closer engagement with prospects in the medical device space.